TTY Biopharm Future Growth
Future criteria checks 2/6
TTY Biopharm is forecast to grow earnings and revenue by 18.7% and 6.5% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 20.8% in 3 years.
Key information
18.7%
Earnings growth rate
18.7%
EPS growth rate
Pharmaceuticals earnings growth | 36.1% |
Revenue growth rate | 6.5% |
Future return on equity | 20.8% |
Analyst coverage | Low |
Last updated | 25 Jan 2024 |
Recent future growth updates
Recent updates
Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly
Apr 02Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?
Mar 15Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?
Feb 25TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Feb 07TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially
Jan 19What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Jan 10TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet
Dec 15How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?
Nov 25Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 6,303 | 1,659 | N/A | 2,113 | 1 |
12/31/2024 | 5,798 | 1,347 | 1,097 | 1,701 | 2 |
12/31/2023 | 5,506 | 1,129 | 986 | 1,085 | N/A |
9/30/2023 | 5,394 | 1,168 | 758 | 891 | N/A |
6/30/2023 | 5,287 | 1,130 | 1,091 | 1,219 | N/A |
3/31/2023 | 5,191 | 1,106 | 1,021 | 1,142 | N/A |
12/31/2022 | 5,062 | 1,094 | 1,100 | 1,236 | N/A |
9/30/2022 | 4,997 | 1,193 | 1,294 | 1,399 | N/A |
6/30/2022 | 4,731 | 1,109 | 1,015 | 1,116 | N/A |
3/31/2022 | 4,609 | 856 | 1,156 | 1,247 | N/A |
12/31/2021 | 4,536 | 832 | 1,182 | 1,256 | N/A |
9/30/2021 | 4,270 | 751 | 873 | 937 | N/A |
6/30/2021 | 4,235 | 720 | 768 | 937 | N/A |
3/31/2021 | 4,092 | 874 | 444 | 619 | N/A |
12/31/2020 | 4,222 | 924 | 344 | 526 | N/A |
9/30/2020 | 4,130 | 693 | 455 | 646 | N/A |
6/30/2020 | 4,255 | 787 | 894 | 980 | N/A |
3/31/2020 | 4,445 | 860 | 1,123 | 1,191 | N/A |
12/31/2019 | 4,466 | 900 | 1,139 | 1,210 | N/A |
9/30/2019 | 4,447 | 1,236 | 1,241 | 1,298 | N/A |
6/30/2019 | 4,204 | 1,263 | 932 | 980 | N/A |
3/31/2019 | 4,110 | 1,499 | 819 | 893 | N/A |
12/31/2018 | 4,036 | 1,461 | 987 | 1,074 | N/A |
9/30/2018 | 4,102 | 1,696 | 899 | 1,013 | N/A |
6/30/2018 | 4,240 | 1,631 | 980 | 1,099 | N/A |
3/31/2018 | 4,173 | 1,379 | 1,127 | 1,237 | N/A |
12/31/2017 | 4,079 | 1,345 | 899 | 997 | N/A |
9/30/2017 | 3,874 | 1,088 | N/A | 980 | N/A |
6/30/2017 | 3,765 | 1,023 | N/A | 1,031 | N/A |
3/31/2017 | 3,795 | 1,134 | N/A | 1,109 | N/A |
12/31/2016 | 3,761 | 1,193 | N/A | 1,227 | N/A |
9/30/2016 | 3,733 | 1,536 | N/A | 1,083 | N/A |
6/30/2016 | 3,612 | 1,565 | N/A | 938 | N/A |
3/31/2016 | 3,389 | 1,393 | N/A | 947 | N/A |
12/31/2015 | 3,195 | 1,211 | N/A | 639 | N/A |
9/30/2015 | 3,058 | 1,133 | N/A | 698 | N/A |
6/30/2015 | 2,929 | 986 | N/A | 725 | N/A |
3/31/2015 | 2,969 | 829 | N/A | 593 | N/A |
12/31/2014 | 2,980 | 780 | N/A | 578 | N/A |
9/30/2014 | 2,976 | 196 | N/A | 409 | N/A |
6/30/2014 | 2,995 | 94 | N/A | 619 | N/A |
3/31/2014 | 2,957 | 124 | N/A | 1,200 | N/A |
12/31/2013 | 3,110 | 587 | N/A | 535 | N/A |
9/30/2013 | 3,262 | 702 | N/A | 473 | N/A |
6/30/2013 | 3,442 | 711 | N/A | 439 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4105's forecast earnings growth (18.7% per year) is above the savings rate (1%).
Earnings vs Market: 4105's earnings (18.7% per year) are forecast to grow slower than the TW market (19.7% per year).
High Growth Earnings: 4105's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4105's revenue (6.5% per year) is forecast to grow slower than the TW market (10.5% per year).
High Growth Revenue: 4105's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4105's Return on Equity is forecast to be high in 3 years time (20.8%)